Pilot and Feasibility Grants
Pilot and Feasibility Grants fund new initiatives and/or support new investigators who are pursuing liver-related research that should lead to R01-type funding or other extramural support at a later date. These awards are for one year, and they provide support for investigators to collect preliminary data sufficient to support a future extramural grant application for independent research and/or to test a novel hypothesis. They are not intended for bridge funding, large projects by established investigators, or supporting or supplementing the ongoing funded research of an investigator.
- Track 1 (N). Junior investigators without independent grant support (excluding career development awards) seeking to establish independence in the field of liver research. **This category of applicant will be given preference.**
- Track 2 (EN). Established investigators with independent grant support—past or present—who have not been involved in liver research and who wish to develop new research directions related to the liver.
- Track 3 (E). Established investigators working in liver-related research who wish to begin a new project representing a major departure from their previous NIH-funded research.
PLRC 2021-2022 Pilot and Feasibility Grant Awardees
PLRC 2020-2021 Pilot and Feasibility Grant Awardees
PLRC 2019-2020 Pilot and Feasibility Grant Awardees
PLRC 2018-2019 Pilot and Feasibility Grant Awardees
PLRC 2017-2018 Pilot and Feasibility Grant Awardees
PLRC 2016-2017 Pilot and Feasibility Grant Awardees
Coulter Program – PLRC Joint Awards
The mission of this grant is to provide awardees with the means to develop a viable path to commercialization via a license to an existing commercial entity or the initiation of a startup company through Pitt’s Innovation Institute. The Award is aimed at developing the commercial potential of healthcare solutions that are based on innovative technologies related to liver health, including disease diagnosis, surgery, treatment, and public health. Projects may be medical devices, diagnostics, healthcare IT/software or drug delivery systems.